tiprankstipranks
Trending News
More News >

LifeMD price target raised to $15 from $12 at BTIG

BTIG raised the firm’s price target on LifeMD (LFMD) to $15 from $12 and keeps a Buy rating on the shares as part of a broader research note in summary of presentations at the recent Boston Digital Health Summit. The firm believe that nearly all companies in its coverage group can and will benefit from AI, though the direct-to-consumer solutions like LifeMD and Hims (HIMS) may be able to drive more value quickly given the relatively high number of engagements with members, especially with respect to obesity health, the analyst tells investors in a research note.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue